Statistics for Elacestrant: a new FDA-approved SERD for the treatment of breast cancer
Total visits
| views | |
|---|---|
| Elacestrant: a new FDA-approved SERD for the treatment of breast cancer | 0 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |